Glenmede Trust’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.5K Hold
334
﹤0.01% 1464
2026
Q1
$17.8K Buy
+334
New +$19.6K ﹤0.01% 1453
2025
Q1
$156K Hold
2,585
﹤0.01% 1235
2024
Q4
$151K Hold
2,585
﹤0.01% 1266
2024
Q3
$153K Hold
2,585
﹤0.01% 1259
2024
Q2
$145K Hold
2,585
﹤0.01% 1224
2024
Q1
$151K Hold
2,585
﹤0.01% 1210
2023
Q4
$140K Hold
2,585
﹤0.01% 1173
2023
Q3
$125K Hold
2,585
﹤0.01% 1133
2023
Q2
$140K Hold
2,585
﹤0.01% 1132
2023
Q1
$140K Sell
2,585
-228
-8% -$12.1K ﹤0.01% 1138
2022
Q4
$148K Buy
2,813
+2,585
+1,134% +$131K ﹤0.01% 1124
2022
Q3
$10K Hold
228
﹤0.01% 1245
2022
Q2
$10K Sell
228
-16
-7% -$872 ﹤0.01% 1255
2022
Q1
$14K Hold
244
﹤0.01% 1280
2021
Q4
$15K Sell
244
-36
-13% -$2.31K ﹤0.01% 1286
2021
Q3
$17K Sell
280
-20
-7% -$1.28K ﹤0.01% 1256
2021
Q2
$17K Hold
300
﹤0.01% 1245
2021
Q1
$15K Hold
300
﹤0.01% 1166
2020
Q4
$15K Buy
+300
New +$15.7K ﹤0.01% 1160
2016
Q1
Sell
-1,260
Closed -$25K 2670
2015
Q4
$25K Buy
+1,260
New +$25.2K ﹤0.01% 1780

Other funds holding IHI

Glenmede Trust's IHI Position: Q2 2026 in Review

Glenmede Trust held its iShares US Medical Devices ETF (IHI) position steady in Q2 2026 at 334 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1464.

Glenmede Trust first reported a position in IHI in Q4 2015 and has held it in 21 quarters since. The position peaked at $156K in Q1 2025. 502 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Glenmede Trust held 334 shares of iShares US Medical Devices ETF worth $16.5K as of Q2 2026.
  • Glenmede Trust left its iShares US Medical Devices ETF share count unchanged in Q2 2026.
  • iShares US Medical Devices ETF made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #1464 holding.
  • Glenmede Trust first reported a position in iShares US Medical Devices ETF in Q4 2015 and has held it in 21 quarters since.
  • Glenmede Trust's iShares US Medical Devices ETF position peaked at $156K in Q1 2025.
  • 502 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.